Often considered a silent disease, MASH frequently presents no noticeable symptoms until substantial liver damage has already occurred, making early detection through regular screenings vital to prevent further progression and complications
Health alert Status: Active Date issued: 19 June 2026 Issued by: Dr Caroline McElnay, Chief Health Officer Issued to: Health professionals and the Victorian community Key messages The department has been notified of six cases of acute liver toxicity associated with an unapproved peptide product in Australia, labelled Retatrutide
Long-term timing considerations As you settle into a GLP-1 protocol over months, your side effect profile typically improves significantly
GLP-1 has also been linked to healthy weight management as it is believed to help regulate food intake by telling the brain that its full
Authored by pharmacy-trained professionals Reviewed by multiple verified experts in the pharmaceutical and healthcare niche Based on trusted sources including FDA, Health Canada, and peer-reviewed clinical studies Regularly reviewed and updated every 90 days to maintain accuracy and trustworthiness About Pandameds.com Pandameds.com is a prescription referral service and help U.S
Am J Clin Nutr 88:12421247 Lithell H, Bruce A, Gustafsson IB et al (1983) A fasting and vegetarian diet treatment trial on chronic inflammatory disorders
